Farther Finance Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $486K | Sell |
|
|||||
|
2025
Q2 | $394K | Buy |
|
|||||
|
2025
Q1 | $186K | Buy |
|
|||||
|
2024
Q4 | $151K | Buy |
|
|||||
|
2024
Q3 | $134K | Buy |
|
|||||
|
2024
Q2 | $144K | Buy |
|
|||||
|
2024
Q1 | $177K | Buy |
|
|||||
|
2023
Q4 | $131K | Buy |
|
|||||
|
2023
Q3 | $9.08K | Sell |
|
|||||
|
2023
Q2 | $20.2K | Sell |
|
|||||
|
2023
Q1 | $33.4K | Buy |
|
|||||
|
2022
Q4 | $447 | Buy |
|